ArticleBiosensors2026
An Intelligent Wearable EMG Sensing Framework for Athlete Neuromuscular Monitoring and Performance Progression Assessment.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electromyography (EMG)-based sensing is an important tool for assessing neuromuscular activity and monitoring athlete development; its reliability depends on electrode placement, signal quality, and accurate identification of muscle activation periods. This study proposes an intelligent EMG sensing framework integrating preliminary electrode placement assessment, muscle activity detection, feature extraction, and regression-based progression prediction. A placement assessment indicated that positioning the electrode adjacent to the innervation zone produced the highest RMS under the tested conditions. A two-stage activity detection method based on clustering and probabilistic modeling achieved an average error of 1.5% and a temporal deviation of 19 ms. Nine time-domain EMG features extracted from the detected activity segments were used to characterize athlete progression and estimate the time required to reach a reference neuromuscular profile. Among the methods, Linear Regression provided the best fit to the data, obtaining R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.